According to new information presented at the American College of Gastroenterology Annual Scientific Meeting, patients taking statins experienced reduced risk for developing esophageal cancer.
In a systematic review and meta-analysis, researchers found that patients who used statins were less likely to develop esophageal cancer. Patients with a longer duration of statin use and those who used statins in addition to nonsteroidal anti-inflammatory drugs and/or aspirin had an ever greater drop in risk.
Experts are excited about the findings of these studies, which support a “protective association” between statin use and esophageal cancer, especially in patients with Barrett’s Esophagus. Given the high mortality rates after a diagnosis of esophageal cancer, these results support chemoprevention trials evaluating statins in populations at high risk of developing cancer.